Renal and splanchnic exchange of human biosynthetic C-peptide in Type 1 (insulin-dependent) diabetes mellitus

15Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Biosynthetic human C-peptide or NaCl (154 mmol·l-1) was given intravenously to 13 Type 1 (insulin-dependent) diabetic patients to determine the renal and splanchnic exchange of C-peptide. Catheters were inserted percutaneously into an artery and a renal and hepatic vein. Infusions of C-peptide were given for 60 min at two dose levels (5 and 30 pmol·kg-1·min-1). Insulin was infused throughout the study (0.5 mU·kg-1·min-1) and plasma glucose was kept constant by a variable glucose infusion. The regional blood flows were measured by indicator dilution techniques. In 11 of the 13 patients basal C-peptide levels were not detectable. The arterial steady-state C-peptide concentration was 0.81±0.10 nmol·l-1 and 2.33±0.30 nmol·l-1 at the low and high rate infusions, respectively. Renal uptake was 124±18 pmol·min-1 at the low infusion corresponding to 39% of the infused amount. At the higher dose C-peptide infusion renal uptake increased to 155±21 pmol·min-1 (p<0.05). Urinary excretion of C-peptide was 7±2 pmol·min-1 at the low dose infusion and increased to 34±6 pmol·min-1 at the high dose infusion (p<0.01). The proportions of infused amount excreted were fairly constant and between 2% and 3%. No net exchange of C-peptide was found across the splanchnic vascular bed. The rate of glucose infusion had to be increased by 35% during the low dose C-peptide, but not during NaCl infusion in order to maintain a constant plasma glucose concentration. Arterial plasma concentrations of noradrenaline increased by 15-25% during both C-peptide and NaCl infusions. It is concluded that in patients with Type 1 diabetes (a) the kidney is the primary site of C-peptide removal, (b) renal metabolism rather than urinary excretion is the dominating process for C-peptide elimination (c) the excreted proportions of an infused amount of C-peptide were fairly constant between 2% and 3% and (d) no hepatic C-peptide catabolism could be detected. © 1991 Springer-Verlag.

References Powered by Scopus

Glucose clamp technique: A method for quantifying insulin secretion and resistance

7149Citations
N/AReaders
Get full text

Radioimmunological determination of human C-peptide in serum

827Citations
N/AReaders
Get full text

Hemoglobin Components in Patients with Diabetes Mellitus

682Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Role of C-peptide in human physiology

251Citations
N/AReaders
Get full text

Positron emission tomography in clinical islet transplantation

138Citations
N/AReaders
Get full text

Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of Type 1 (insulin-dependent) diabetic patients

131Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sjöberg, S., Johansson, B. L., Östman, J., & Wahren, J. (1991). Renal and splanchnic exchange of human biosynthetic C-peptide in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia, 34(6), 423–428. https://doi.org/10.1007/BF00403181

Readers over time

‘16‘19‘20‘21‘22‘23‘2401234

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

67%

Researcher 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

60%

Nursing and Health Professions 1

20%

Chemistry 1

20%

Save time finding and organizing research with Mendeley

Sign up for free
0